Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Merz, Lilly and Daiichi-Sankyo breach ABPI code

Pharma companies 'named and shamed' for inappropriate marketing in the UK

- PMLiVE

US management shake-up at Valeant

New appointments in several senior roles following Medicis acquisition

- PMLiVE

Pfizer launches personalised lung cancer drug Xalkori in UK

Becomes first treatment on the market for ALK-positive NSCLC

- PMLiVE

Salaries: a figure of speech

Zenopa survey reveals what ‘would be’ medical writers in the UK can expect to earn

- PMLiVE

Bray Leino opens health and wellbeing PR practice

Appoints Hayley Knight to run Rx, OTC and wellbeing services

ABPI London offices

Biosimilars should be routinuely assessed by NICE, says ABPI

Calls for biosimilars to go through full HTA process

- PMLiVE

Teva plans revamp as 2013 revenues expected to fall short

Expects increased competition for biggest-selling drug Copaxone

- PMLiVE

Pharma R&D costs up tenfold since 1970s

Average cost to bring a drug to market now $1.9bn, according to the Office for Health Economics

- PMLiVE

Gorsky named chairman of J&J

Completes transition from former CEO and chair Bell Weldon

- PMLiVE

Genzyme makes Brendan Martin UK and Ireland manager

Replaces Paul Drohan who returns to Canada

- PMLiVE

FDA approves Exelixis’ Cometriq for rare thyroid cancer

Genomics-based discovery company also submits the drug to EU regulators

- PMLiVE

RSA appoints Michael Huberts as executive search consultant

He joins from Tokyo-based executive search firm Optia Partners

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links